Sacks Ian 4/A
4/A · HEALTHEQUITY, INC. · Filed Apr 29, 2022
Insider Transaction Report
Form 4/AAmended
Sacks Ian
Director
Transactions
- Award
Common Stock
2022-02-01+1,073→ 148,574 total - Award
Common Stock
2022-02-01+1,455→ 147,501 total
Holdings
- 15,000
Stock Option (right to buy)
Exercise: $25.39Exp: 2025-03-26→ Common Stock (15,000 underlying) - 15,000
Stock Option (right to buy)
Exercise: $14.00Exp: 2024-07-30→ Common Stock (15,000 underlying) - 15,000
Stock Option (right to buy)
Exercise: $21.27Exp: 2026-02-01→ Common Stock (15,000 underlying) - 8,024
Stock Option (right to buy)
Exercise: $66.06Exp: 2030-02-01→ Common Stock (8,024 underlying)
Footnotes (4)
- [F1]This amendment is being filed to correct an error in the number of shares of Common Stock reported as acquired in the original Form 4.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the date of the issuer's annual stockholder meeting held in the current fiscal year. Vested shares will be delivered to the reporting person upon vesting.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vested as to 269 shares on February 1, 2022. The remaining restricted stock units vest as to 268 shares on each of May 1, August 1, and November 1, of 2022. Vested shares will be delivered to the reporting person upon vesting.
- [F4]The option is immediately exercisable.